Yüklüyor......

MicroRNAs in pancreatic cancer diagnosis and therapy

Pancreatic cancer remains a disease with very poor prognosis (only 5-6% of patients are still alive after five years). Attempts to improve the results of treatment of pancreatic cancer focus on a better understanding of the pathogenesis, and non-invasive diagnostic methods (genetic testing from peri...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cent Eur J Immunol
Asıl Yazarlar: Słotwiński, Robert, Lech, Gustaw, Słotwińska, Sylwia Małgorzata
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Polish Society of Experimental and Clinical Immunology 2018
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6305615/
https://ncbi.nlm.nih.gov/pubmed/30588176
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/ceji.2018.80051
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!